Partner Therapeutics, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Partner Therapeutics, Inc.
Quantité totale PI 27
Rang # Quantité totale PI 55 360
Note d'activité PI 2,4/5.0    29
Rang # Activité PI 26 547
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

6 4
4 0
11 0
2
 
Dernier brevet 2025 - Long-acting granulocyte macropha...
Premier brevet 2021 - Granulocyte-macrophage colony-st...
Dernière marque 2024 - LEUKINE
Première marque 2018 - X

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Effects of gm-csf addition on humoral modulation and fcgr2b binding in allergy, infection and imm...
P/S Pharmaceutical preparations for the treatment of immune system deficiencies, namely, granulocyte-...
Invention Humoral modulation in vaccinated and virally infected subjects with granulocyte-macrophage colony...
Invention Viral infection modulation in vaccinated subjects treated with granulocyte-macrophage colony-stim...
2023 Invention Granulocyte-macrophage colony-stimulating factor-based treatments for pulmonary or respiratory di...
Invention Long-acting granulocyte macrophage-colony stimulating factor. The present disclosure relates gen...
Invention Long-acting granulocyte macrophage-colony stimulating factor. Colony Stimulating Factor, CSF, ref...
Invention Granulocyte-macrophage colony-stimulating factor-based treatments for neurodegenerative or neurol...
Invention Granulocyte-macrophage colony-stimulating factor-based dermatological pathology treatments. The p...
2022 Invention Granulocyte-macrophage colony-stimulating factor-based cancer treatments. The present disclosure...
Invention Granulocyte-macrophage colony-stimulating factor-based cancer treatments. The present disclosure ...
2021 Invention Manufacture of granulocyte macrophage-colony stimulating factor. The present disclosure relates ...
Invention Manufacture of granulocyte macrophage-colony stimulating factor. The present disclosure relates t...
Invention Granulocyte macrophage-colony stimulating factor mutants. The present invention is based on the ...
Invention Granulocyte macrophage-colony stimulating factor mutants. The present invention is based on the d...
Invention Granulocyte-macrophage colony-stimulating factor-based infection treatments. The present disclos...
Invention Granulocyte-macrophage colony-stimulating factor-based infection treatments. The present disclosu...
2018 P/S Pharmaceuticals for the treatment of acute radiation syndrome Pharmaceutical research and develop...
P/S pharmaceuticals for the treatment of acute radiation syndrome Pharmaceutical research and develop...
P/S Pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of blood disorders...